Quality of life and mental health in the locked-in-state-differences between patients with amyotrophic lateral sclerosis and their next of kin.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 07 03 2022
accepted: 14 06 2022
revised: 14 06 2022
pubmed: 6 7 2022
medline: 14 10 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

For both patients with amyotrophic lateral sclerosis (ALS) and their next of kin (NOK), the maintenance of quality of life (QoL) and mental health is particularly important. First studies suggest significant discrepancies between QoL reports by patients and NOK, but little is known for advanced ALS stages. To address this issue, we screened 52 ALS patients in incomplete locked-in state (iLIS). Final results were obtained for 15 couples of iLIS patients and NOK. We assessed patients' and NOK's subjective QoL, depression and anxiety and NOK's caregiver burden. Gaze controlled questionnaires allowed direct assessment of patients. Patients and NOK self-reported comparable, mostly moderate to high levels of QoL. Of note, NOK indicated stronger anxiety symptoms. Higher anxiety levels in NOK were associated with stronger caregiver burden and reduced QoL. No significant misjudgment of patient's QoL by the NOK was evident, while patients overestimated NOK's global QoL. However, NOK with severe caregiver burden and depression symptoms gave poorer estimations of patients' QoL. This relationship is relevant, considering NOK's impact on life critical treatment decisions. While the daily time NOK and patient spend together was positively correlated with NOK's QoL and mental health, this was not reversely found for the patients. Our results suggest that NOK adapt less successfully to the disease and concomitant experience of loss and point to an urgent need for specialized psychosocial support. The findings emphasize the importance of direct psychological wellbeing assessment of both patients and NOK in clinical practice, enabled by eye-tracking technology for patients in iLIS.

Identifiants

pubmed: 35790562
doi: 10.1007/s00415-022-11238-0
pii: 10.1007/s00415-022-11238-0
pmc: PMC9553779
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5910-5925

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 13GW0482
Organisme : Innovationsausschuss beim Gemeinsamen Bundesausschuss
ID : 01VSF16026

Informations de copyright

© 2022. The Author(s).

Références

Health Qual Life Outcomes. 2020 Nov 23;18(1):371
pubmed: 33225955
J Neurol. 2011 Oct;258(10):1801-4
pubmed: 21461685
Palliat Med. 1995 Jul;9(3):207-19
pubmed: 7582177
Qual Life Res. 2014 Sep;23(7):2025-30
pubmed: 24585129
Amyotroph Lateral Scler. 2010 Oct;11(5):469-74
pubmed: 20235757
J Neurol. 2014 Mar;261(3):518-25
pubmed: 24413639
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):537-45
pubmed: 23725553
Palliat Support Care. 2010 Mar;8(1):75-82
pubmed: 20163763
J Neurol. 2017 Apr;264(4):639-646
pubmed: 28120043
Neurotherapeutics. 2015 Apr;12(2):394-402
pubmed: 25502407
Eur J Neurol. 2008 Nov;15(11):1231-6
pubmed: 18803649
J Clin Nurs. 2018 Dec;27(23-24):4321-4330
pubmed: 29964322
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
J Neurol. 2013 Nov;260(11):2836-43
pubmed: 23989341
Palliat Med. 2012 Jun;26(4):368-78
pubmed: 21712334
Qual Life Res. 2011 May;20(4):569-74
pubmed: 21086185
Neurology. 2002 Jan 22;58(2):320-2
pubmed: 11805269
J Clin Nurs. 2017 Oct;26(19-20):3188-3199
pubmed: 27874996
Dtsch Arztebl Int. 2008 Jun;105(23):397-403
pubmed: 19626161
Psychol Health Med. 2012;17(5):621-8
pubmed: 22313252
Psychophysiology. 2002 Nov;39(6):781-90
pubmed: 12462506
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):68-76
pubmed: 24070371
J Mot Behav. 2014;46(4):233-8
pubmed: 24731126
Neurosci Biobehav Rev. 2020 Apr;111:1-11
pubmed: 31917162
N Engl J Med. 2017 Jul 13;377(2):162-172
pubmed: 28700839
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):53-59
pubmed: 27534566
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):606-610
pubmed: 30039719
Am J Occup Ther. 2017 May/Jun;71(3):7103190010p1-7103190010p7
pubmed: 28422627
J Sex Marital Ther. 2008;34(2):115-32
pubmed: 18224547
J Palliat Med. 2004 Aug;7(4):551-7
pubmed: 15353099
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):317-327
pubmed: 31116037
Ann Behav Med. 2009 Apr;37(2):197-206
pubmed: 19350337
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):546-52
pubmed: 23834069
Eur J Neurol. 2012 Mar;19(3):360-75
pubmed: 21914052
Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):291-2
pubmed: 26121170
Amyotroph Lateral Scler. 2010;11(1-2):116-21
pubmed: 19551536
Prog Brain Res. 2009;177:339-51
pubmed: 19818912
Neurology. 2005 Jul 12;65(1):68-74
pubmed: 16009887
Funct Neurol. 2013 Apr-May;28(2):115-9
pubmed: 24125561
Neurology. 2019 Sep 3;93(10):e938-e945
pubmed: 31391247
J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):285-290
pubmed: 31937581
Ann Neurol. 2017 Feb;81(2):310-315
pubmed: 28074605
Palliat Support Care. 2015 Aug;13(4):909-16
pubmed: 24991842
J Neurol. 2010 Sep;257(9):1473-81
pubmed: 20383521
Qual Life Res. 2001;10(2):149-58
pubmed: 11642685
Arch Phys Med Rehabil. 2007 Apr;88(4):529-36
pubmed: 17398257
Palliat Med. 2018 Jan;32(1):231-245
pubmed: 28671483
Behav Sci (Basel). 2020 Jan 10;10(1):
pubmed: 31936812
Neurology. 2007 Mar 20;68(12):923-6
pubmed: 17372127
Acta Neurol Scand. 2017 Dec;136(6):631-638
pubmed: 28523721
Front Neurol. 2018 Jul 27;9:603
pubmed: 30100896
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):456-62
pubmed: 19922140
Palliat Support Care. 2010 Jun;8(2):207-13
pubmed: 20557668
J Neurol Sci. 2016 Nov 15;370:269-273
pubmed: 27772773
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):185-91
pubmed: 24720451
Patient Prefer Adherence. 2012;6:829-38
pubmed: 23226006
Neurology. 2003 Jan 14;60(1):122-3
pubmed: 12525733
Amyotroph Lateral Scler. 2007 Aug;8(4):243-54
pubmed: 17653923
BMC Geriatr. 2014 Feb 20;14:23
pubmed: 24555474
Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):235-241
pubmed: 30654658
Neurorehabil Neural Repair. 2005 Sep;19(3):182-93
pubmed: 16093409
Amyotroph Lateral Scler. 2011 Jan;12(1):45-51
pubmed: 20849323
Psychother Psychosom Med Psychol. 2002 Mar-Apr;52(3-4):141-50
pubmed: 11941521
Front Psychol. 2015 Sep 14;6:1197
pubmed: 26441696
J Neurol. 2015 Jun;262(6):1526-32
pubmed: 25904206
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):775-81
pubmed: 26341327
J Clin Nurs. 2013 Aug;22(15-16):2141-9
pubmed: 23387287
CNS Drugs. 2007;21(4):279-91
pubmed: 17381183
Amyotroph Lateral Scler. 2011 Jul;12(4):297-302
pubmed: 21428731
Int J Psychol. 2013;48(3):194-205
pubmed: 22731673
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):367-377
pubmed: 28631956

Auteurs

Elisa Aust (E)

Department of Neurology, Technische Universität Dresden, Dresden, Germany.

Katharina Linse (K)

Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Dresden, Dresden, Germany.

Sven-Thomas Graupner (ST)

Engineering Psychology and Applied Cognitive Research, Technische Universität Dresden, Dresden, Germany.

Markus Joos (M)

Interactive Minds Research, Interactive Minds Dresden GmbH, Dresden, Germany.

Daniel Liebscher (D)

Interactive Minds Research, Interactive Minds Dresden GmbH, Dresden, Germany.

Julian Grosskreutz (J)

Precision Neurology, University of Lübeck, Lübeck, Germany.

Johannes Prudlo (J)

Department of Neurology, University of Rostock, Rostock, Germany.
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, Rostock, Germany.

Thomas Meyer (T)

Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

René Günther (R)

Department of Neurology, Technische Universität Dresden, Dresden, Germany.
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Dresden, Dresden, Germany.

Sebastian Pannasch (S)

Engineering Psychology and Applied Cognitive Research, Technische Universität Dresden, Dresden, Germany.

Andreas Hermann (A)

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.
Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.
Translational Neurodegeneration Section "Albrecht Kossel," Department of Neurology, University Medical Center Rostock, University of Rostock, Gehlsheimer Straße 20, 18147, Rostock, Germany. Andreas.Hermann@med.uni-rostock.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH